'Simply stunning'--trastuzumab in HER2-positive breast cancer.
Doggrell
Sheila A
SA
School of Science, Charles Darwin University, PO Box 41246, Casuarina, Northern Territory, 0811, Australia. s_doggrell@yahoo.com